03/07/2025

The long journey to develop a drug against an “undruggable” target in cancer

Laura Soucek — Vall d´Hebron, Barcelona

07/07/2025

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies

Juan José Montero Valderrama — Institute of Molecular Oncology and Functional Genomics (IMO), Technical University of Munich (TUM). Munich

10/07/2025

Decoding the RAS-PI3K-YAP signalling axis in CAFs during lung cancer progression

Marta Alcón — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)

14/07/2025

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress.

Cristian Prieto — IBCII - Univ. Frankfurt

30/06/2025

Antibody-Drug Conjugates Targeting EGFR in Ovarian Cancer

Sheila Almaraz — Centro de Investigación del Cáncer (Universidad de Salamanca - CSIC)

19/06/2025

Structure of Centromeric Chromatin and Its Consequences for Genome Stability

Carlos Sacristán López — Hubrecht Institute, Utrech (Netherlands)

16/06/2025

Metabolic Control of Cell Fate in Regeneration and Cancer

Almudena Chaves Pérez — Memorial Sloan Kettering Cancer Centre (NY)

13/06/2025

defensa de tesis: Unraveling the role of RNA modifications in immune evasion and tumor progression in prostate cancer

Ana Macrina Añazco Guenkova — Programa de doctorado de biociencias: biología y clínica de cáncer